Fluorodeoxyglucose Positron Emission Tomography Studies in the Diagnosis and Staging of Transitional Cell Carcinoma
The introduction of positron emission tomography (PET) has allowed scientists and clinicians to measure biochemical and physiological processes in vivo. Although PET has been in existence since the 1960s, it did not gain complete clinical acceptance until roughly a decade ago. At that time, Di Chiro et al demonstrated the ability of PET to differentiate between recurrent brain tumor and radiation necrosis.5 This prompted the recognition of PET as a valid method of tumor imaging.
KeywordsPositron emISSIon Tomography Positron emISSIon Tomography Imaging Transitional Cell Carcinoma Radiation Necrosis Positron emISSIon Tomography Examination
Unable to display preview. Download preview PDF.